Canada
Tuberculosis profile
Population  2012 35 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.067 (0.067–0.068) 0.19 (0.19–0.19)
Mortality (HIV+TB only) 0.012 (<0.01–0.015) 0.03 (0.03–0.04)
Prevalence  (includes HIV+TB) 2.1 (0.9–3.8) 6.1 (2.6–11)
Incidence  (includes HIV+TB) 1.6 (1.4–1.8) 4.6 (4–5.2)
Incidence (HIV+TB only) 0.11 (0.096–0.12) 0.31 (0.28–0.36)
Case detection, all forms (%) 100 (91–120)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 478 (30) Relapse 58 (64)
Smear-negative 464 (30) Treatment after failure    
Smear-unknown / not done 110 (7) Treatment after default    
Extrapulmonary 519 (33) Other 33 (36)
Other 0 (0)      
Total new 1 571   Total retreatment 91  
           
Other (history unknown) 24        
Total new and relapse 1 629   Total cases notified 1 686  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.7 1.4 1.1
Age < 15 7 49 52
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 62   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 71  
Retreatment 56  
TB/HIV 2012 Number (%)
TB patients with known HIV status 716 (42)
HIV-positive TB patients 57 (8)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.57 (0.23–1.2) 1.6 (0.04–8.5)
MDR-TB cases among notified pulmonary
TB cases
6 (2–12) 1 (0–8)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 244 (136%) 63 (69%) 1 325
Laboratory-confirmed MDR-TB cases 7 1 9
Patients started on MDR-TB treatment     8
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data